Renal function in mice poisoned with oral uranium and treated with ethane-1-hydroxy-1,1-bisphosphonate (EHBP)

Health Physics

Volumn 85, Issue 3, 2003, Pages 343-347

  Martinez, A B ^b   Mandalunis, P M ^a   Bozal, C B ^a   Cabrini, R L ^a   Ubios, A M ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b NONE

Author keywords

Chelation; Intake, radionuclide; Mice; Uranium

Indexed keywords

ANESTHETIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; CREATININE; ETHER; ETIDRONIC ACID; HEAVY METAL; URANIUM; URANYL NITRATE; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFECT; DRUG EFFICACY; EVALUATION; FOOD CONTAMINATION; HISTOPATHOLOGY; INHALATION; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY INJURY; LETHAL DOSE; MALE; MOUSE; MOUSE STRAIN; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PURIFICATION; RADIATION DOSE; RADIATION EXPOSURE; RADIOACTIVE CONTAMINATION; RISK ASSESSMENT; SURVIVAL RATE; TISSUE REPAIR; URANIUM MINE; UREA BLOOD LEVEL; WATER CONTAMINATION; WORKER;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, ORAL; ANIMALS; CREATININE; DIPHOSPHONATES; KIDNEY; KIDNEY DISEASES; MALE; MICE; MICE, INBRED BALB C; RADIATION TOLERANCE; RADIATION-PROTECTIVE AGENTS; URANIUM; UREA;

ANIMALIA;

EID: 0042662875     PISSN: 00179078     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004032-200309000-00010     Document Type: Article

References (28)

1. Basinger MA, Forti RL, Burka L, Jones MM, Mitchell WM, Johnson JE, Gibbs SJ. Phenolic chelating agents as antidotes for acute uranyl acetate intoxication in mice. J Toxicol Environm Health 11:237-246; 1983.
2. Catsch, A. Die wirkung einiger chelatbuldner auf die akute toxicitat von uranylnitrate. Klin. Wochenschr. 37:657-660; 1959. (In German.)
3. de Rey BM, Lanfranchi HE, Cabrini RL. Percutaneous absorption of uranium compounds. Environm Res 30:480-491; 1983.
4. de Rey BM, Lanfranchi HE, Cabrini RL. Deposition pattern and toxicity of subcutaneously implanted uranium dioxide in rats. Health Phys 46:688-692; 1984.
5. Domingo JL, Llobet JM, Tomas JM, Corbella JE. Acute toxicity of uranium in rats and mice. Bull Environm Contam Toxicol 39:168-174; 1987.
6. Domingo JL, Llobet JM, Ortega A, Paternain JE, Corbella JE. The effects of repeated parenteral administration of chelating agents on the distribution and excretion of uranium. Res Comm Chem Pathol Pharmacol 64:161-164; 1989.
7. Domingo JL, Ortega A, Llobet JM, Corbella JE. Effectiveness of chelation therapy with time after acute uranium intoxication. Fundam Appl Toxicol 14:88-95; 1990.
8. Domingo JL, Colomina MT, Llobet JM, Jones MM, Singh PK, Campbell RA. The action of chelating agents in experimental uranium intoxication in mice: variations with structure and time of administration. Fundam and Appl Toxicol 19:350-357; 1992.
9. Durbin PW, Kullgren B, Xu J, Raymond KN. New agents for in vivo chelation of uranium (VI): efficacy and toxicity in mice of multidentate catecholate and hydroxypyridinonate ligands. Health Phys 72:865-879; 1997.
10. Fisenne IM, Welford GA. Natural U concentrations in soft tissues and bone of New York City residents. Health Phys 50:739-746; 1986.
11. Fisenne IM, Perry PM, Harley NH. Uranium in humans. Radiat Protect Dosim 24:127-131; 1988.
12. Fleisch H. Bisphosphonates in bone disease. New York: The Parthenon Publishing Group; 1995.
13. Henge-Napoli MH, Archimbaud M, Ansoborlo E, Metivier H, Gourmelon P. Efficacy of 3, 4, 3-LIHOPO for reducing the retention of uranium in rat after acute administration. Int J Radiat Biol 68:389-393; 1995.
14. Henge-Napoli MH, Ansoborlo E, Chazel V, Houpert P, Paquet F, Gourmelon P. Efficacy of ethane-1, 1-bisphosphonate (EHBP) for the decorporation of uranium after intramuscular contamination in rats. Int J Radiat Biol 75:1473-1477; 1999.
15. Hodge HC. Toxicity of uranium compounds. In: Hodge HC, Stannard JN, Hursch JB eds. Uranium-plutonium-transplutonic elements. Berlin: Springer-Verlag; 1973a: 12-15.
16. Hodge HC. Treatment of uranium poisoning. In: Hodge HC, Stannard JN, Hursch JB eds. Uranium-plutonium-transplutonic elements. Berlin: Springer-Verlag; 1973b: 52-54.
17. Leggett RW. The behavior and chemical toxicity of uranium in the kidney: A reassessment. Health Phys 57:365-383; 1989.
18. Martinez AB, Cabrini RL, Ubios AM. Orally administered ethane-1-hydroxy-1, 1-biphosphonate reduces the lethal effect of oral uranium poisoning. Health Phys 78:668-671; 2000.
19. Ortega A, Domingo JL, Gomez M, Corbella J. Treatment of experimental acute uranium poisoning by chelating agents. Pharmacol Toxicol 64:247-251; 1989.
20. Research Triangle Institute. Toxicological profile for uranium: Draft for public comment. Washington, DC: U.S. Department of Health & Human Services; 1997.
21. Steel RGD, Forrie JH. Principles and procedures of statistics. New York: McGraw-Hill Books Company Inc.; 1960.
22. Stradling GN, Gray SA, Moody JC, Ellender M. Efficacy of TIRON for enhancing the excretion of uranium from the rat. Hum and Exptl Toxicol 10:195-198; 1991.
23. Todorovsky D, Kulev I. On the uranium content in some technogenic products potential environmental pollutants. J Radioanal Nucl Chem 176:405-413; 1993.
24. Ubios AM, Braun EM, Cabrini RL. Lethality due to uranium intoxication is prevented by ethane 1-hydroxy-1, 1-diphosphonate (EHBP). Health Phys 66:540-544; 1994.
25. Ubios AM, Marzorati M, Cabrini RL. Skin alterations induced by long-term exposure to uranium and their effect on permeability. Health Phys 72:713-715; 1997.
26. Ubios AM, Braun EM, Cabrini RL. Effect of biphosphonates on abnormal mandibular growth of rats intoxicated with uranium. Health Phys 75:610-613; 1998.
27. Vucic N, Ilic Z. Extraction and spectrophotometric determination of uranium in phosphate fertilizers. J Radioanal Nucl Chem 1:113-120; 1989.
28. Walinder G. Metabolism and sites of effects of uranium after incorporation along different routes in mice, rabbits and piglets. Radiat Protect Dosim 26:89-95; 1989.